Cytek Biosciences (CTKB) Profit After Tax (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.20% |
| Dec 31, 2025 | -854.23% |
| Sep 30, 2025 | 17.27% |
| Jun 30, 2025 | 51.03% |
| Mar 31, 2025 | -204.29% |
| Dec 31, 2024 | 783.83% |
| Sep 30, 2024 | 111.86% |
| Jun 30, 2024 | -69.14% |
| Mar 31, 2024 | -212.10% |
| Dec 31, 2023 | 187.68% |
| Sep 30, 2023 | -43.03% |
| Jun 30, 2023 | 35.54% |
| Mar 31, 2023 | -292.89% |
| Dec 31, 2022 | 306.57% |
| Sep 30, 2022 | 223.65% |
| Jun 30, 2022 | 67.47% |
| Mar 31, 2022 | -548.05% |
| Dec 31, 2021 | -196.24% |
| Sep 30, 2021 | -87.04% |
| Jun 30, 2021 | 2,517.65% |